PREPARATION AND IN VIVO EVALUATION OF SOLID DISPERSIONS USING REPAGLINIDE
Abstract
In the present study, immediate release solid dispersion of Repaglinide was formulated by solvent evaporation technique. Repaglinide solid dispersions were prepared using PEG 8000, Pluronic F 127 and Gelucire 44/14 by solvent evaporation method. A 3-factor, 3-level central composite design employed to study the effect of each independent variable on dependent variables. FTIR studies revealed that no drug excipient interaction takes place. From powder X-ray diffraction (p-XRD) and by scanning electron microscopy (SEM) studies it was evident that polymorphic form of Repaglinide has been converted into an amorphous form from crystalline within the solid dispersion formulation. The correlation coefficient showed that the release profile followed Higuchi model anomalous behavior and hence release mechanism was indicative of diffusion. From in vivo studies, the AUC0→24 h and peak plasma concentration (Cmax) was doubled when compared with pure drug. In addition, in vitro dissolution efficiency was well correlated with in vivo pharmacokinetic parameters. The obtained results suggested that developed solid dispersion might be an efficacious approach for enhancing the solubility and bioavailability of Repaglinide.
Keywords:
Repaglinide, Diabetes mellitus, Solid dispersion, Solvent evaporation method, Bioavailability studiesDOI
https://doi.org/10.25004/IJPSDR.2018.100502References
2. Van de Waterbeemd H. The fundamental variables of the bio pharmaceutics classification system a commentary. Eur J Pharm Sci. 1998; 7:1–3.
3. Leuner C, DressmanJ. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000; 50 (1): 47 – 60.
4. Wagh VT, Jagtap VA, Shaikh TJ, Nandedkar SY. Formulation and Evaluation of Glimepiride Solid Dispersion Tablets for Their Solubility Enhancement. J. Adv. Sci. Res. 2012; 3(4): 36-41.
5. Pouton CW. Formulation of Poorly water-soluble drugs for oral administration Physicochemical and physiological issues and the lipid formulation classification systems. Eur. J. Pharm. Sci. 2006; 29: 278-87.
6. Koh PT, Chuah JN, Talekar M, Gorajana A, Garg S. Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems. Indian. J. Pharm. Sci. 2013; 75(3): 291-301.
7. Ha ES, Choo GH, Baek IH, Min-Soo, Kim. Formulation Characterization and In Vivo Evaluation of Celecoxib-PVP Solid Dispersion Nano particles Using Supercritical Antisolvent Process Molecules. 2014; 19:20325-20339.
8. Serajuddin ATM. Solid Dispersion of Poorly Water-Soluble Drugs Early Promises Subsequent Problems and Recent Breakthroughs. J. Pharm. Sci. 1999; 88 (10): 1058-1066.
9. Manvi P, Narendra P, Bhaskar VH. Preparation Characterization and In Vitro Evaluation of Repaglinide Binary Solid Dispersions with Hydrophilic Polymers. Int. J. Drug. Devel. Res. 2011; 3 (2):111-121.
10. Culy C, Jarvis B. Repaglinide a review of its therapeutic use in type 2 diabetes mellitus. Drugs. 2001; 61:1625–1660
11. Malaisse W, Repaglinide. A new oral anti diabetic agent a review of recent preclinical studies. Eur J Clin Invest. 1999; 29:21–29.
12. Purvis T, Mattucci ME, Crisp MT, Johnston KP, Williams RO. Rapidly dissolving repaglinide powders produced by the ultra-rapid freezing process. AAPS Pharm Sci Tech. 2007; 8(3): E1 - E9.
13. Ahuja N, Katare OP, Singh B. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur. J. Pharm. Biopharm. 2007; 65: 26–38.
14. Guyot M, Fawaz F, Bildet J, Bonini F, Lagueny AM. Bioavailability of norfloxacin from PEG 6000 solid dispersion and cyclodextrin inclusion complexes in rabbits. Int. J. Pharm. 1995; 123: 53-63.
15. Kim EJ, Chun MK, Jang JS, Lee IH, Lee KR, Choi HK. Preparation of a solid dispersion of felodipine using a solvent wetting method.Eur. J. Pharm. Biopharm. 2006; 64: 200 -205.
16. Vippagunta SR, Maul KA, Tallavajhala S, Grant DJW. Solid-state characterization of nifedipine solid dispersions. Int. J. Pharm. 2002; 236: 111–123.
17. Nauna Kettanech-Wold. Use of Experimental Design in the Pharmaceutical Industry. Journal of Pharmaceutical and Biomedical Analysis. 1991; 9(8): 605-610.
18. Zerrouk N, Chemtob C, Arnaud P, Toscani S, Dugue J. In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions. Int J Pharm. 2001; 225(1-2):49-62.
19. Ramanji Reddy T, Dhachinamoorthi D, Chandra Sekhar KB. Development of RP-HPLC method for Metformin and Repaglinide in rabbit plasma. Int J Pharm Pharm Sci. 2002; 4(2): 311-313.
Published
Abstract Display: 553 
PDF Downloads: 0 How to Cite
Issue
Section
Copyright (c) 2018 I. Srinivas, D.V.R.N Bhikshapathi
This work is licensed under a Creative Commons Attribution 4.0 International License.
